| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVTE | Common Stock | Purchase | $1,549,944 | +928,110 | +13% | $1.67* | 7,893,678 | 17 Jun 2024 | See footnotes | F1, F2, F3 |
| holding | AVTE | Common Stock | 987,244 | 17 Jun 2024 | See footnotes | F3, F4 | |||||
| holding | AVTE | Common Stock | 311,170 | 17 Jun 2024 | See footnotes | F3, F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.51 to $1.75 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | Held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). |
| F3 | RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
| F4 | Held directly by the Nexus Fund. |
| F5 | Held directly by the Account. |
Mr. Joshua Resnick, a Senior Managing Director of the Adviser, serves on the Issuer's board of directors.